TP53INP1 and type 2 diabetes mellitus: By integrating omics data, we have inferred the genetic mechanisms for the 3 genes CAMK1D, TP53INP1, and ATP5G1; the inferred mechanisms suggest that enhancer-promoter interactions with DNA methylation play an important role in mediating the effects of genetic variants on T2D risk.